Related Experiment Video
Updated: Mar 16, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
Antiviral Medication in Sexually Transmitted Diseases. Part III: Hepatitis B, Hepatitis C
Anna Majewska, Beata Mlynarczyk-Bonikowska1, Magdalena Malejczyk
1Department of Dermatology and Venereology, 82a Koszykowa Str, 02-008 Warsaw, Medical University of Warsaw, Poland.
Abstract:
In the previous parts of the series the antiviral agents used in genital herpes, genital HPV infection and therapeutic options in HIV infections were presented. The sexual contact is one of the major routes in the transmission of HBV and also possible modes of transmission of HCV. In this review we present the clinical indications, mechanisms of action, and side effects of presently available medication for the management of HBV and HCV infections. Currently a revolution is happening in the therapy of chronic hepatitis, especially caused by HCV. Direct-acting antivirals promise to open a new era in treating of chronic HCV infection. Efficacious, simplified and well tolerated interferon-free, and in some cases ribavirin-free regiments are available already and several other inhibitors currently are in the clinical trials.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Viruses with RNA Genomes
Subviral Agents
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...

